Highest potency resveratrol and pterostilbene supplement launched

Print |

Pterostilbenes are the new resveratrol

pterostilbene and resveratrol supplement

New York City, N.Y, April 18, 2011 — Biotivia, a world leading developer of pharmaceutical grade resveratrol based supplements has created a revolutionary, high potency pterostilbene supplement called PteroMax. Pterostilbene is the molecule contained in Blueberries and some other fruits in very small amounts.

Pterostilbene is the key component of this unique supplement, but Biotivia have taken this further by making PteroMax the most potent Multi-Stilbene, Multi-Polyphenol complex on the market.

James Betz, Founder and CEO of Biotivia, said: “The polyphenols in PteroMax are powerful antioxidants which greatly increase the bio-availability of the resveratrol in the blood and tissues. PteroMax has been modeled on over four years of extensive work from the world’s top stilbene and resveratrol professionals.”

The pterostilbene in PteroMax boosts the potency and efficacy of the resveratrol by activating various genes, proteins, and signaling pathways that provide greater overall antioxidant and cognitive support benefits. Polydatin takes this one step further and, with the OPCs and polyphenols in PteroMax, they catalyze the entire multi-stilbene formulation.

Betz continued: “Pterostilbenes dramatically enhance the bio-availability of the polydatin and resveratrol in PteroMax. They also provide protection against free-radicals and have shown extraordinary anti-inflammatory, cognitive improvement, cholesterol lowering, and immune boosting effects. PteroMax contains 100mg of pure Pterostilbene in each capsule. This is 400 times the amount contained in the one other pterostilbene supplement for sale in the U.S.”

To read more about PteroMax, please visit http://www.biotivia.com/pteromax.html

###

About Biotivia LLC

Biotivia was established in 1992 in Vienna, Austria as a supplier of natural raw materials and biologically active botanics to the supplement and functional food industries and to researchers and scientific institutions worldwide. The company evolved into one of the world’s leading developers and suppliers of unique science-based nutritional supplements and award winning skin care therapies, with most of their products centered around the use of concentrated resveratrol and complementary botanical extracts.

Biotivia presently has US offices in New York, Los Angeles, Kansas City and international offices in the UK, Spain, Austria, Denmark, Italy, Germany, Singapore, Xi’an, China and Mumbai, India.

Beyond its strong consumer base, the company currently supplies researchers, physicians and scientists at Harvard, Stanford, Yale, Georgetown, The Albert Einstein Medical Center, University of Texas, M.D. Anderson Cancer Center, Health Canada, and the University of California. Transmax and Bioforte in particular are being investigated by several major university medical schools as a possible treatment for a variety of conditions that seriously impair the health and well being of millions of people around the world. Biotivia most recently signed an agreement to supply Transmax to the University of Ferrara for use in three human clinical trials in Italy and Egypt on its possible use by Thalassemia sufferers as an alternative to the whole blood transfusions which such patients now require monthly. The Albert Einstein Medical College published a study which elucidated the beneficial effects of Biotivia’s proprietary resveratrol on glucose tolerance and mitochondria function in pre-diabetic subjects. Bioforte was also shown to more than double brain blood flow in a study done at the University of Northumbria in the UK.

Biotivia’s resveratrol products, Transmax and Bioforte, have been independently assessed by Consumer Labs, the leading American quality watchdog, and were deemed both ‘most potent’ and ‘best value’. Transmax has been certified as an investigational drug by the NIH, an endorsement of its safety and purity.

Most of Biotivia’s supplements have been certified Vegan by the American Vegetarian Association.

Important Caveat: Neither PteroMax nor any Biotivia product has been definitively shown to diagnose, prevent or cure any age related diseases. PteroMax is not intended to diagnose, prevent, treat or cure any disease. Studies done in vitro and on animals do not always translate into the same biological effect when taken by human subjects. The statements herein have not been reviewed or approved by the US FDA. All Biotivia supplements are manufactured in state of the art government inspected pharmaceutical facilities in accordance with CGMP and USP standards.